Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2335 Target Snapshot

Lysosomal Pro-X carboxypeptidase · SINGLE PROTEIN · Homo sapiens

472Compounds
46Assays
1Approved Drugs
513.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P42785. Use UniProt P42785 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P42785 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Lysosomal Pro-X carboxypeptidase as ChEMBL target CHEMBL2335, mapped to UniProt P42785. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Lysosomal Pro-X carboxypeptidase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2335
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P42785
Lysosomal Pro-X carboxypeptidase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Lysosomal Pro-X carboxypeptidase is the right protein anchor across sources, using UniProt P42785 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLysosomal Pro-X carboxypeptidase
UniProt AccessionP42785
Component TypeProtein
Sequence Length496 aa

Lysosomal Pro-X carboxypeptidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Lysosomal Pro-X carboxypeptidase, mapped to UniProt P42785. Sequence length is 496 aa.

Mapped IDP42785
Review nameLysosomal Pro-X carboxypeptidase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
4
Phase II
Assay Mix

Activity Type Distribution

IC50453.0
KI59.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3910523 10.46 IC50 0.035 Preclinical
CHEMBL3919329 10.29 IC50 0.051 Preclinical
CHEMBL3086040 10.1 IC50 0.079 Preclinical
CHEMBL1950440 9.77 IC50 0.17 Preclinical
CHEMBL3086037 9.74 IC50 0.18 Preclinical
CHEMBL3652599 9.74 IC50 0.18 Preclinical
CHEMBL2022787 9.7 IC50 0.2 Preclinical
CHEMBL2022793 9.7 IC50 0.2 Preclinical
CHEMBL2023210 9.7 IC50 0.2 Preclinical
CHEMBL1938522 9.52 IC50 0.3 Preclinical
Distribution

pChEMBL Value Distribution

24
5.0
15
5.5
37
6.0
40
6.5
64
7.0
74
7.5
61
8.0
49
8.5
38
9.0
12
9.5
pChEMBL
Approved Drugs

Approved Drugs

Assay Landscape

Assay Landscape

46
Total Assays
459
Tested Compounds
1
Assay Types
Binding — 46 assays, 459 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 37 399 7.4
tissue-based format 4 9 6.2
assay format 3 24 8.5
cell-based format 2 27 4.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine